The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival comparison in patients with and without brain metastases treated with osimertinib for metastatic EGFR mutation positive non-small cell lung cancer (NSCLC).
 
Danilo Giffoni de Mello Morais Mata
No Relationships to Disclose
 
Maria Luisa Romero
No Relationships to Disclose
 
Carlos Amir Carmona Gonzalez
No Relationships to Disclose
 
Alia Thawer
Honoraria - Abbvie; GlaxoSmithKline Canada; Knight Pharmaceuticals; Novartis Canada Pharmaceuticals Inc; Pfizer
Consulting or Advisory Role - Amgen; Ipsen; Lilly; Novartis; Pfizer; Sandoz-Novartis
Research Funding - AstraZeneca; Novartis
 
Mark Doherty
No Relationships to Disclose
 
Ines B. Menjak
Consulting or Advisory Role - Amgen
Other Relationship - AstraZeneca; Takeda